Fundz

Neuvivo Closes On Additional Funding Round For Np001 Development

PRIVATEMay 26, 2022

Round Type

Funding Round

Palo AltoBiotechnology

Description

Neuvivo, a late-clinical stage biopharmaceutical company developing a new ALS treatment, today announced that it has closed on an additional round of financing led by an international investment group. The Bay Area-based company is currently in regulatory discussions with the FDA around its lead candidate, NP001 for ALS.

Quick answer

Neuvivo raised an undisclosed amount in a Funding Round round, dated May 26, 2022. Neuvivo is based in Palo Alto, California, United States.

How much did Neuvivo raise?
Neuvivo raised an undisclosed amount in a Funding Round round on May 26, 2022.
What does Neuvivo do?
Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases.
Where is Neuvivo based and how big is it?
Neuvivo is based in Palo Alto, California, United States.
Who are the decision-makers at Neuvivo?
Fundz holds 1 contact at Neuvivo. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Neuvivo that raised within 45 days of this round, from Fundz verified event records.

  • ImmunityBio raised $11M on July 9, 2022.
  • Ensysce Biosciences raised $4.2M (Seed) on July 8, 2022.
  • Annexon raised $130M (Post-IPO Equity) on July 8, 2022.
  • Novasenta Inc. raised $10M on July 8, 2022.
  • INSIGHT OPTICS, INC. raised $578K (Seed) on July 8, 2022.
  • Bactana raised $385K (Seed) on July 7, 2022.

Who to call at Neuvivo, and when

A new round usually means Neuvivo is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neuvivo raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neuvivo, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neuvivo. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neuvivo

Location

Palo Alto, California, United States

About

Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. We have developed a patented macrophage-targeted technology, NP001, that addresses chronic inflammation, a key factor in the progressive loss of motor function in ALS. NP001 has received Orphan Drug and Fast Track designation by the FDA as it addresses a clear unmet medical need. We are working to move this compound toward approval and delivering an effective and safe new treatment for ALS.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neuvivo raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Neuvivo's next move

See what Strategic adds

Neuvivo raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.